Thambisetty MR - Search Results

1

Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung.

Thambisetty MR, Scherzer CR, Yu Z, Lennon VA, Newman NJ. Thambisetty MR, et al. J Neuroophthalmol. 2001 Sep;21(3):164-7. doi: 10.1097/00041327-200109000-00002. J Neuroophthalmol. 2001. PMID: 11725180 Review.

2

Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.

Thambisetty M, Howard R. Thambisetty M, et al. JAMA Neurol. 2023 May 1;80(5):431-432. doi: 10.1001/jamaneurol.2023.0207. JAMA Neurol. 2023. PMID: 36912850

3

Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.

Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, Karikari TK, Blennow K, Zetterberg H, Jedynak BM, Thambisetty M, Ferrucci L, Resnick SM. Bilgel M, et al. Alzheimers Dement. 2023 Oct;19(10):4335-4345. doi: 10.1002/alz.13157. Epub 2023 May 22. Alzheimers Dement. 2023. PMID: 37216632 Free PMC article.

4

Computational Approaches to Assess Abnormal Metabolism in Alzheimer's Disease Using Transcriptomics.

Lüleci HB, Uzuner D, Çakır T, Thambisetty M. Lüleci HB, et al. Methods Mol Biol. 2023;2561:173-189. doi: 10.1007/978-1-0716-2655-9_9. Methods Mol Biol. 2023. PMID: 36399270

5

Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease.

Liu KY, Villain N, Ayton S, Ackley SF, Planche V, Howard R, Thambisetty M. Liu KY, et al. Brain Commun. 2023 Jun 2;5(3):fcad175. doi: 10.1093/braincomms/fcad175. eCollection 2023. Brain Commun. 2023. PMID: 37389302 Free PMC article. Review.

6

Lecanemab trial in AD brings hope but requires greater clarity.

Thambisetty M, Howard R. Thambisetty M, et al. Nat Rev Neurol. 2023 Mar;19(3):132-133. doi: 10.1038/s41582-022-00768-w. Nat Rev Neurol. 2023. PMID: 36609712 No abstract available.

7

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.

Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY; Alzheimer’s Disease Neuroimaging Initiative. Zhou X, et al. Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1697-1706. doi: 10.1073/pnas.1715554115. Epub 2018 Feb 5. Proc Natl Acad Sci U S A. 2018. PMID: 29432188 Free PMC article.

8

Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.

Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, Kac PR, Karikari TK, Blennow K, Zetterberg H, Jedynak BM, Thambisetty M, Ferrucci L, Resnick SM. Bilgel M, et al. medRxiv [Preprint]. 2023 Apr 21:2023.01.12.23284439. doi: 10.1101/2023.01.12.23284439. medRxiv. 2023. Update in: Alzheimers Dement. 2023 Oct;19(10):4335-4345. doi: 10.1002/alz.13157 PMID: 36711545 Free PMC article. Updated. Preprint.

9

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.

Desai RJ, Mahesri M, Lee SB, Varma VR, Loeffler T, Schilcher I, Gerhard T, Segal JB, Ritchey ME, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Desai RJ, et al. Brain Commun. 2022 Oct 4;4(5):fcac247. doi: 10.1093/braincomms/fcac247. eCollection 2022. Brain Commun. 2022. PMID: 36330433 Free PMC article.

10

Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.

Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M; BIOCARD Research Team. Miller MI, et al. Neurobiol Aging. 2015 Jan;36 Suppl 1:S3-S10. doi: 10.1016/j.neurobiolaging.2014.06.032. Epub 2014 Aug 29. Neurobiol Aging. 2015. PMID: 25444602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters